A randomized, double-blind placebo-controlled trial for Zishen Yutai Pill for endometrial repair in patients after artificial abortion

Centre for Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Patients aged 18 to 40 years;
•2. The patients who were diagnosed as early intrauterine pregnancy and asked for termination of pregnancy and accepted abortion;
•3. The number of previous abortion 1-3;
•4. Menstrual cycle in the first three months of pregnancy, 25-35 days and 3-10 days;
•5. Objects who have been healthy without contraindications;
•6. Patients who voluntarily cooperate with observation and treatment and have signed informed consent.

•1. Patients who used proprietary Chinese medicine and hormone within the past month;
•2. Subjects with previous allergic history to the test drug;
•3. Patients with poor general conditions and intolerable to surgery;
•4. Patients with previous endocrine abnormalities, uterine organic lesions and reproductive system tumors;
•5. Patients with genital malformation, tumor or acute genital inflammation (such as acute pelvic inflammation, acute vaginitis, etc.);
•6. The disabled patients (blind, deaf, dumb, mental disorder, mental disorder, physical disability) and the mentally ill patients specified by law;
•7. Patients whose body temperature was above 37.5 degree C twice before operation;
•8. Patients who have had the previous uterine cleaning for more than 4 times;
•9. Patients with severe hepatorenal insufficiency.

发起方

Centre for Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology